Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Companion Animal Arthritis Market

Companion Animal Arthritis Market Size

  • Report ID: GMI10785
  • Published Date: Aug 2024
  • Report Format: PDF

Companion Animal Arthritis Market Size

Companion Animal Arthritis Market size was valued at approximately USD 3.4 billion and is projected to grow at a CAGR of 7.2% from 2024 and 2032. Arthritis, a common ailment in companion animals like dogs and cats, involves inflammation and degradation of joint cartilage and the underlying bone. This condition results in pain, stiffness, and reduced mobility, severely affecting the quality of life for these pets. The rising incidence of arthritis in companion animals, especially in dogs and cats, mirrors broader trends in pet ownership, an aging demographic, and evolving lifestyle factors.

 

One of the primary drivers for the growth of the companion animal arthritis market is the increasing ownership of pets. This surge in pet ownership has led to a heightened demand for companion animal healthcare products, including medications and supplements. According to the National Pet Owners Survey by the American Pet Products Association, approximately 86.9 million American families, or 66%, own pets ranging from birds and cats to dogs and ferrets. Furthermore, the global increase in pet adoption, combined with technological advancements in veterinary medicine—such as enhanced diagnostic tools and more effective treatment options—bolsters market growth. These innovations not only enhance treatment efficacy but also broaden the spectrum of treatable conditions.
 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global companion animal arthritis market was valued at around USD 3.4 billion in 2023 and will register a 7.2% CAGR, driven largely by rising pet ownership, and higher incidence rate of arthritis among dogs and cats.

The medication segment was worth USD 1.5 billion in 2023, owing to its role in symptom management, in consort with advancements in veterinary medicine, such as better diagnostics, stronger medications, and comprehensive treatment protocols.

In 2023, North America captured a 45.6% share of the global companion animal arthritis market, with anticipated strong growth driven by increasing pet ownership, greater awareness of animal health, and advancements in veterinary care.

American Regent, Inc., Bayer AG (Bayer Animal Health), Boehringer Ingelheim International GmbH, CEVA Santé Animale, Dechra Pharmaceuticals plc, Elanco Animal Health Incorporated, Eltech K-Laser s.r.l., Medivet, Norbook Laboratories Ltd., Nutramax Laboratories Veterinary Sciences, Inc, Vetoquinol SA, Vibrac, and Zoetis, Inc.

Companion Animal Arthritis Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 13
  • Tables & Figures: 343
  • Countries covered: 22
  • Pages: 196
 Download Free Sample